Abterra Biosciences
Pre-clinicalAbterra Bio is reimagining antibody discovery and sequencing by harnessing the latest next-generation sequencing, mass spec, machine learning.
Founded
2019
Focus
Antibodies
About
Abterra Bio is reimagining antibody discovery and sequencing by harnessing the latest next-generation sequencing, mass spec, machine learning.
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile